CFR Subpart B

CFR Subpart B
in effect

21 C.F.R. § 207.17 Who must register?

(a) Unless exempt under section 510(g) of the Federal Food, Drug, and Cosmetic Act or this part, all manufacturers, repackers, relabelers, and salvagers must register each domestic establishment that manufactures, repacks, relabels, or salvages a drug, or an animal feed bearing or containing a new animal drug, and each foreign establishment that manufactures, repacks, relabels, or salvages a drug, or an animal feed bearing or containing a new animal drug, that is imported or offered for import into the United States. When operations are conducted at more than one establishment and common ownership and control among all the establishments exists, the parent, subsidiary, or affiliate company may submit registration information for all establishments. (b) Private label distributors who do not also manufacture, repack, relabel, or salvage drugs are not required to register under this part. FDA will accept registration or listing information submitted by a private label distributor only if it is acting as an authorized agent for and submitting information that pertains to an establishment that manufactures, repacks, relabels, or salvages drugs.

21 C.F.R. § 207.21 When must initial registration information be provided?

(a) Registrants must register each domestic establishment no later than 5 calendar days after beginning to manufacture, repack, relabel, or salvage a drug or an animal feed bearing or containing a new animal drug at such establishment. (b) Registrants must register each foreign establishment before a drug or an animal feed bearing or containing a new animal drug manufactured, repacked, relabeled, or salvaged at the establishment is imported or offered for import into the United States.

21 C.F.R. § 207.25 What information is required for registration?

Registrants must provide the following information: (a) Name of the owner or operator of each establishment; if a partnership, the name of each partner; if a corporation, the name of each corporate officer and director, and the place of incorporation; (b) Each establishment's name, physical address, and telephone number(s); (c) All name(s) of the establishment, including names under which the establishment conducts business or names by which the establishment is known; (d) Registration number of each establishment, if previously assigned by FDA; (e) A Unique Facility Identifier in accordance with the system specified under section 510 of the Federal Food, Drug, and Cosmetic Act. (f) All types of operations performed at each establishment; (g) Name, mailing address, telephone number, and email address of the official contact for the establishment, as provided in § 207.69(a); and (h) Additionally, with respect to foreign establishments subject to registration, the name, mailing address, telephone number, and email address must be provided for: (1) The United States agent, as provided in § 207.69(b); (2) Each importer in the United States of drugs manufactured, repacked, relabeled, or salvaged at the establishment that is known to the establishment; and (3) Each person who imports or offers for import such drug to the United States.

21 C.F.R. § 207.29 What are the requirements for reviewing and updating registration information?

(a) Expedited updates. Registrants must update their registration information no later than 30 calendar days after: (1) Closing or selling an establishment; (2) Changing an establishment's name or physical address; or (3) Changing the name, mailing address, telephone number, or email address of the official contact or the United States agent. A registrant, official contact, or United States agent may notify FDA about a change of information for the designated official contact or United States agent, but only a registrant is permitted to designate a new official contact or United States agent. (b) Annual review and update of registration information. Registrants must review and update all registration information required under § 207.25 for each establishment. (1) The first review and update must occur during the period beginning on October 1 and ending December 31 of the year of initial registration, if the initial registration occurs prior to October 1. Subsequent reviews and updates must occur annually, during the period beginning on October 1 and ending December 31 of each calendar year. (2) The updates must reflect all changes that have occurred since the last annual review and update. (3) If no changes have occurred since the last registration, registrants must certify that no changes have occurred.

Starting a business? Corpus forms LLCs in all 50 states and DC.